COVID-19 Disease in Patients With Recurrent Pericarditis During Treatment With Anakinra: Comment on the Article by Navarro-Millán et al

Arthritis Rheumatol. 2021 Aug;73(8):1562-1563. doi: 10.1002/art.41702. Epub 2021 Jul 2.

Authors

Enrica Negro¹, Lucia Trotta¹, Massimo Pancrazi¹, Emanuele Bizzi¹, Martino Brenna¹, Vartan Mardigyan², Massimo Imazio³, Antonio Brucato⁴

Affiliations

¹ Fatebenefratelli Hospital, Milan, Italy.
² McGill University and Jewish General Hospital, Montreal, Quebec, Canada.
³ Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
⁴ Università di Milano andFatebenefratelli Hospital, Milan, Italy.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Humans
Interleukin 1 Receptor Antagonist Protein
Pericarditis* / chemically induced
Pericarditis* / drug therapy
Recurrence
SARS-CoV-2

Substances

Interleukin 1 Receptor Antagonist Protein